Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,443,424
New position
Shares Held
9,710
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,808
of 4,153 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Axxion S.A. holds $46,943,687 across 10 Drug Manufacturers - General names. ABBV ranks #4 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,502 | $20,992,425 | |
| 2 | PFE |
Pfizer Inc
|
399,565 | $9,621,525 | |
| 3 | JNJ |
Johnson & Johnson
|
24,549 | $6,234,709 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
9,710 | $2,443,424 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,507 | $2,378,149 | |
| 6 | AZN |
Astrazeneca PLC
|
9,607 | $1,821,679 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
12,294 | $1,553,223 | |
| 8 | AMGN |
Amgen Inc
|
1,968 | $712,652 |
All Filings in ABBV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,443,424 | 9,710 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||